1 “..., the evidence about the harms of any of these treatments was limited. LIMITATIONS: Most studies were of poor...”

2 “..., the evidence about the harms of any of these treatments was limited. LIMITATIONS: Most studies were of poor...”

3 Subjects: “...Treatment Outcome...”

4 Subjects: “...Treatment Outcome...”

5 Subjects: “...Treatment Outcome...”

6 Subjects: “...Treatment Outcome...”

7 “... in the treatment of major depressive disorder (MDD), dysthymia, subsyndromal depression, seasonal affective...”

8 “... SC (Rebif(r)) or interferon beta-1b (Betaseron(r)) based on 2 head-to-head trials. Evidence...”

9

10

11 “... affect choice of treatment, clinical outcomes, and safety? (2) How do the timing and route...”

12 “... affect choice of treatment, clinical outcomes, and safety? (2) How do the timing and route...”

13 “... SOE). One head-to-head trial comparing exenatide with liraglutide reported a slightly greater...”